Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1530
Publisher
MDPI AG
Online
2019-10-11
DOI
10.3390/cancers11101530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosomal miRNA Cargo as Mediator of Immune Escape Mechanisms in Neuroblastoma
- (2019) Thomas D. Schmittgen CANCER RESEARCH
- miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy
- (2019) Huan Tang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer
- (2019) Bhagyashri Kulkarni et al. DRUG DISCOVERY TODAY
- Emerging roles of exosomal miRNAs in breast cancer drug resistance
- (2019) Hamid Najminejad et al. IUBMB LIFE
- HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL
- (2018) Xuehai Bian et al. BIOCHEMICAL PHARMACOLOGY
- HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1
- (2018) Oluwaseun Adebayo Bamodu et al. EXPERIMENTAL CELL RESEARCH
- Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population
- (2018) Hiva Danesh et al. GENE
- Let-7c inhibits the proliferation, invasion and migration of glioma cells via targeting E2F5
- (2018) Mengyi Huang et al. ONCOLOGY RESEARCH
- Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites
- (2018) Yu Xie et al. Cell Death & Disease
- Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
- (2018) Amit Singh et al. Nutrients
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells
- (2018) Deniz Mortazavi et al. CYTOTECHNOLOGY
- Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid
- (2018) Marina Perona et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Regulation of microRNA function in animals
- (2018) Luca F. R. Gebert et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Effects of let‑7c on the proliferation of ovarian carcinoma cells by targeted regulation of CDC25a gene expression
- (2018) Wei Zhang et al. Oncology Letters
- Effect of exosomal miRNA on cancer biology and clinical applications
- (2018) Zhenqiang Sun et al. Molecular Cancer
- Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity
- (2017) Katrina V. Good et al. Epigenetics
- The role of exosomes and miRNAs in drug-resistance of cancer cells
- (2017) Duc-Hiep Bach et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2
- (2017) Yao-jun Zhou et al. LIFE SCIENCES
- Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer
- (2017) Xiaonan Fu et al. ONCOLOGY REPORTS
- Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways
- (2017) Yi-Jin Chen et al. PLoS One
- CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
- (2017) Dawoon E. Jung et al. Scientific Reports
- Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor
- (2016) Shinya Sato et al. CANCER RESEARCH
- HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia
- (2016) T.-H. Lai et al. CLINICAL CANCER RESEARCH
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
- (2015) C. M. Adams et al. CANCER RESEARCH
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
- (2015) Paul G Richardson et al. Expert Review of Anticancer Therapy
- MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence
- (2015) Joon-Ho Cho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells
- (2015) Hyun Min Jung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
- (2015) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
- (2015) Lee M Krug et al. LANCET ONCOLOGY
- HDAC Inhibitors Target HDAC5, Upregulate MicroRNA-125a-5p, and Induce Apoptosis in Breast Cancer Cells
- (2015) Tsung-Hua Hsieh et al. MOLECULAR THERAPY
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma
- (2015) K-Y Lin et al. ONCOGENE
- Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
- (2015) S. P. Iyer et al. ONCOLOGIST
- MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma
- (2015) Xiuming Zhu et al. PLoS One
- HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
- (2015) Alessandro Canella et al. Oncotarget
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
- (2015) Xin Qin et al. Frontiers in Oncology
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks
- (2014) Anne Trécul et al. BIOCHEMICAL PHARMACOLOGY
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- (2014) Francine Foss et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes
- (2014) Hyang Sook Seol et al. CANCER LETTERS
- Belinostat: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
- (2014) S Hibino et al. Oncogenesis
- Epigenetic regulation of microRNA expression in renal cell carcinoma
- (2013) Miriam Schiffgen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3
- (2013) Bingtian Zhao et al. CANCER LETTERS
- Up-regulation of miR-146b and Down-regulation of miR-200b Contribute to the Cytotoxic Effect of Histone Deacetylase Inhibitors onras-Transformed Thyroid Cells
- (2013) Eleonora Borbone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer
- (2013) Chi-qi Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma
- (2013) Shi-Yun Cui et al. MOLECULAR CANCER RESEARCH
- Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism
- (2013) T. Murray-Stewart et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of proliferation, sprouting, tube formation and Tie2 signaling of lymphatic endothelial cells by the histone deacetylase inhibitor SAHA
- (2013) HSUEH-TSEN CHENG et al. ONCOLOGY REPORTS
- HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
- (2013) Ilaria Lepore et al. PLoS One
- A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells
- (2012) Curt Balch et al. CANCER BIOLOGY & THERAPY
- Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines
- (2012) Pietro Di Fazio et al. EXPERIMENTAL CELL RESEARCH
- In vivo redox state of Human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
- (2012) J. Ungerstedt et al. FREE RADICAL BIOLOGY AND MEDICINE
- Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
- (2012) Reena Buurman et al. GASTROENTEROLOGY
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster
- (2012) Karen J. Humphreys et al. MOLECULAR CARCINOGENESIS
- A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts
- (2012) Judit Ribas et al. NUCLEIC ACIDS RESEARCH
- Secreted microRNAs: a new form of intercellular communication
- (2012) Xi Chen et al. TRENDS IN CELL BIOLOGY
- Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
- (2011) D. Sampath et al. BLOOD
- Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
- (2011) L. Kretzner et al. CANCER RESEARCH
- Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination
- (2011) Miglena Koprinarova et al. DNA REPAIR
- miR-605joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
- (2011) Jiening Xiao et al. EMBO JOURNAL
- Epigenetic regulation of microRNA-375 and its role in melanoma development in humans
- (2011) Joseph Mazar et al. FEBS LETTERS
- miR-200a Regulates Nrf2 Activation by TargetingKeap1mRNA in Breast Cancer Cells
- (2011) Gabriel Eades et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer
- (2011) Hai-Bo Han et al. JOURNAL OF PATHOLOGY
- The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells
- (2011) Bridgette Collins-Burow ONCOLOGY REPORTS
- The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon Cancer
- (2011) Shien Hu et al. PLoS One
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3
- (2010) Y. Tsukamoto et al. CANCER RESEARCH
- Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
- (2010) Cliona Grant et al. Expert Review of Anticancer Therapy
- Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma
- (2010) Suresh S. Ramalingam et al. Journal of Thoracic Oncology
- MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivo
- (2010) R. K. Srivastava et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells
- (2010) Ju-Hee Lee et al. MOLECULES AND CELLS
- Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
- (2010) Sushant K. Kachhap et al. PLoS One
- Epigenetic regulation of microRNA expression in colorectal cancer
- (2009) Eva Bandres et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis
- (2009) S. Inoue et al. MOLECULAR CANCER THERAPEUTICS
- Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis
- (2009) Katia R.M. Leite et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Widespread changes in protein synthesis induced by microRNAs
- (2008) Matthias Selbach et al. NATURE
- The let-7 family of microRNAs
- (2008) Sarah Roush et al. TRENDS IN CELL BIOLOGY
- Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
- (2007) F Condorelli et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started